Multi-omics analysis reveals gut microbiota remodeling and lipid metabolism regulation during the treatment of nonalcoholic fatty liver disease with Yindan Pinggan capsule
YDPG alleviates NAFLD by modulating the gut-liver axis, restoring gut microbial balance, and correcting metabolic disorders, demonstrating its potential as a multi-target therapeutic agent for NAFLD.
Institutions
- Shanxi University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Liaoning University of Traditional Chinese Medicine (CN)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
- China Academy of Chinese Medical Sciences (CN)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1186/s13020-026-01351-x
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00